Abiopharma

🔍 Savage William Jacob (Executive)

Company: Disc Medicine, Inc. (IRON)

Report Date: 2026-04-13

Detailed Transactions and Holdings:

• Sold 3,531 shares of Common Stock at $66.1209 per share (Direct)
  Date: 2026-04-13 | Code: S | equity_swap_involved: false | shares_owned_after: 81,680.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,200 shares of Common Stock at $66.8073 per share (Direct)
  Date: 2026-04-13 | Code: S | equity_swap_involved: false | shares_owned_after: 79,480.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on October 2, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.50 to $66.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.57 to $67.00, inclusive.